SynthesisCurrent neuropharmacology2015
Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review.
Synthesis in Current neuropharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
71 citing papers in PubMed, 216 citations in OpenAlex.
- Stanozolol, an anabolic-androgenic steroid, modulates expression of receptors and disrupts uterine histoarchitecture in Mus musculus.Journal of molecular histology · 2026Article
- Mental health in elite athletes: International Olympic Committee consensus statement (2026).British journal of sports medicine · 2026Article
- Study protocol of the eating and nutritional habits in athletes and controls longitudinal examination - ENHANCE Study.Discover mental health · 2026Article
- Enhanced games and performance-optimized athletes: anticipating the orthopedic challenges, a narrative review.Acta orthopaedica et traumatologica turcica · 2026Review
- Testosterone abuse in Brazil: a growing public health challenge.Clinics (Sao Paulo, Brazil) · 2026Article
- Exercise addiction risk in recreational athletes: a cross-sectional study of psychological distress and food choice motivations in Jordan.Discover mental health · 2026Article
- Health consequences of anabolic steroids: a sexual-medicine perspective.International journal of impotence research · 2026Review
- The influence of self-esteem and self-efficacy on doping susceptibility and intention in amateur athletes and exercisers.Frontiers in sports and active living · 2026Article
- Impact of Anabolic-Androgenic Steroid Abuse on the Cardiovascular System: Molecular Mechanisms and Clinical Implications.International journal of molecular sciences · 2025Review
- Cognitive Behavioral Therapy for Muscle Dysmorphia and Anabolic Steroid-Related Psychopathology: A Randomized Controlled Trial.Pharmaceuticals (Basel, Switzerland) · 2025Article
- Nandrolone Abuse Prior to Head Trauma Mitigates Endoplasmic Reticulum Stress, Mitochondrial Bioenergetic Deficits, and Markers of Neurodegeneration.Molecular neurobiology · 2025Article
- Changing trends in anabolic-androgenic steroid use within Scottish prisons: Detection, prevalence, and quantitation.Drug testing and analysis · 2025Article
- Prevalence and Correlates of Anabolic-Androgenic Steroid Use in Australian Adolescents.Nutrients · 2025Article
- Psychological correlates of performance-enhancing drug use: Emotional, cognitive, and social functioning in long-term and short-term users.Frontiers in psychiatry · 2025Article
- Article
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024Review
- Mental health problems in Somalia after decades of humanitarian crises: a qualitative exploration of perceptions and experiences.Tropical medicine and health · 2024Article
- Long-term effects of doping with anabolic steroids during adolescence on physical and mental health.Orthopadie (Heidelberg, Germany) · 2024Article
- Supraphysiological testosterone levels from anabolic steroid use and reduced sensitivity to negative facial expressions in men.Psychopharmacology · 2024Article
- Sleep pathology and use of anabolic androgen steroids among male weightlifters in Norway.BMC psychiatry · 2024Article
11 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not uncommon. AAS-using athletes are frequently present with psychiatric symptoms and disorders, mainly somatoform and eating, but also mood, and schizophrenia-related disorders. Some psychiatric disorders are typical of athletes, like muscle dysmorphia. This raises the issue of whether AAS use causes these disorders in athletes, by determining neuroadaptive changes in the reward neural circuit or by exacerbating stress vulnerability, or rather these are athletes with premorbid abnormal personalities or a history of psychiatric disorders who are attracted to AAS use, prompted by the desire to improve their appearance and control their weights. This may predispose to eating disorders, but AASs also show mood destabilizing effects, with longterm use inducing depression and short-term hypomania; withdrawal/discontinuation may be accompanied by depression. The effects of AASs on anxiety behavior are unclear and studies are inconsistent. AASs are also linked to psychotic behavior. The psychological characteristics that could prompt athletes to use AASs have not been elucidated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.